This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Repeat Aortic Valve Surgery or Transcatheter Valve-in-Valve Therapy: We Need a Randomized Trial

Saturday, August 1, 2020

Submitted by


Source Name: Journal American College of Cardiology


Michael A Borger, Matthias Raschpichler, Raj Makkar

This JANS Note is an editorial in response to a recent publication by Deharo et al comparing TAVR valve-in-valve versus redo-SAVR demonstrating improved short-term outcomes with TAVR ViV.  The detail limitations of this study and provide a persuasive argument for the need of a randomized trial comparing both modalities.  

Add comment

Log in or register to post comments